The latest GOLD Report brings big changes to the therapeutic approach to chronic obstructive lung disease (COPD). This user-friendly, clinically relevant reference from our Partner in Health, AstraZeneca, will help you with GOLD recommendations and algorithms for Assessment and Management, including triple therapy.
View the quick guide below or view a PDF.
